Welcome to our dedicated page for Bank Hapoalim news (Ticker: BKHPF), a resource for investors and traders seeking the latest updates and insights on Bank Hapoalim stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bank Hapoalim's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bank Hapoalim's position in the market.
Bank Hapoalim (OTC:BKHPF) reported first quarter 2026 results showing net profit of NIS 2,124 million and ROE of 13.0%, despite a special banks tax that reduced ROE by 130–140 bps annually.
Credit grew 3.3% QoQ and 14.0% YoY; the NPL ratio fell to 0.44% with 330% coverage. Credit loss expenses were 0.03%. The Board approved a 50% payout: NIS 850 million dividend (NIS 0.65 per share) and NIS 212 million in buybacks.
Income from regular financing activity rose 2% QoQ; the financial margin edged up to 2.44%. Fee income increased 0.5% QoQ and 5.3% YoY. Expenses declined 10.3% QoQ (1.6% excluding a Q4 2025 one-off), with a cost-income ratio of 36.6%.
Net credit to the public reached NIS 519 billion and deposits NIS 603 billion. The CET1 ratio was 11.71%, above regulatory and internal targets, and LCR stood at 128%. The allowance for credit losses totaled NIS 8.9 billion, 1.68% of total credit.